Defining the minimal detectable change in scores on the eight-item morisky medication adherence scale;Definiendo el cambio mínimo detectable en la puntuación de laescala morisky de adherencia a medicamentos de 8 puntos

Annals of Pharmacotherapy

Volumn 45, Issue 5, 2011, Pages 569-575

  Muntner, Paul ^a   Joyce, Cara ^b   Holt, Elizabeth ^c   He, Jiang ^b   Morisky, Donald ^d   Webber, Larry S ^b   Krousel Wood, Marie ^c,e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b TULANE UNIVERSITY   (United States)

^c OCHSNER CLINIC FOUNDATION   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypertension; Medication adherence; Morisky medication adherence scale 8 (MMAS 8); Retest; Self report; Test retest

Indexed keywords

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MORISKY MEDICATION ADHERENCE SCALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SELF REPORT; TELEPHONE;

AGED; ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; QUESTIONNAIRES; WEIGHTS AND MEASURES;

EID: 79957623430     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P677     Document Type: Article

References (29)

1. Muntner P, Judd SE, Krousel-Wood M, McClellan WM, Safford MM. Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. Am J Kidney Dis 2010;56:447-57.DOI 10.1053/j.ajkd.2010.02.348
2. Krousel-Wood MA, Muntner P, Islam T, Morisky DE, Webber LS. Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults. Med Clin North Am 2009;93:753-69.DOI 10.1016/j.mcna.2009.02.007
3. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
4. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med 1992;327:776-81.
5. Di Matteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002;40: 794-811.
6. Krousel-Wood M, Hyre A, Muntner P, Morisky D. Methods to improve medication adherence in patients with hypertension: current status and future directions. Curr Opin Cardiol 2005;20:296-300.
7. Burnier M, Santsc V, Favrat B, Brunner HR. Monitoring compliance in resistant hypertension: an important step in patient management. J Hypertens Suppl 2003;21:S37-S42.
8. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999;37:846-57.
9. Hamilton GA. Measuring adherence in a hypertension clinical trial. Eur J Cardiovasc Nurs 2003;2:219-28.
10. Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs 2000;15:90-6.
11. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004;19:357-62.
12. Hawkshead J, Krousel-Wood M. Techniques for measuring medication adherence in hypertensive patients in outpatient settings: advantages and limitations. Disease Management and Health Outcomes 2007;15:109-18.
13. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD. Persistence with treatment for hypertension in actual practice. CMAJ 1999;160:31-7.
14. Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. J Clin Epidemiol 2003;56:520-9.
15. Ogedegbe G, Harrison M, Robbins L, Mancuso CA, Allegrante JP. Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study. Ethn Dis 2004;14:3-12.
16. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008;10:348-54.
17. Islam T, Muntner P, Webber LS, Morisky DE, Krousel-Wood MA. Cohort study of medication adherence in older adults (CoSMO): extended effects of Hurricane Katrina on medication adherence among older adults. Am J Med Sci 2008;336:105-10.
18. Sakthong P, Chabunthom R, Charoenvisuthiwongs R. Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes. Ann Pharmacother 2009;43:950-57. DOI 10.1345/aph.1L453
19. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 2009;15:59-66.
20. Marx RG, Menezes A, Horovitz L, Jones EC, Warren RF. A comparison of two time intervals for test-retest reliability of health status instruments. J Clin Epidemiol 2003;56:730-5.
21. Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977;33:363-74.
22. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
23. Weir JP. Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. J Strength Cond Res 2005;19:231-40. DOI 10.1519/15184.1
24. Al-Qazaz HKh, Hassali MA, Shafie AA, Sulaiman SA, Sundram S, Morisky DE. The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version. Diabetes Res Clin Pract 2010;90:216-21. DOI 10.1016/j.diabres.2010.08.012
25. Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York, NY: McGraw-Hill, 1994.
26. Hyre AD, Krousel-Wood MA, Muntner P, Kawasaki L, DeSalvo KB. Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. J Clin Hypertens (Greenwich) 2007;9: 179-86.
27. Hill MN, Bone LR, Kim MT, Miller DJ, Dennison CR, Levine DM. Barriers to hypertension care and control in young urban black men. Am J Hypertens 1999;12:951-8.
28. Payne KA, Caro JJ, Daley WL, et al. The design of an observational study of hypertension management, adherence and pressure control in Blood Pressure Success Zone Program participants. Int J Clin Pract 2008;62:1313-21. DOI 10.1111/j.1742-1241.2008.01840.x
29. McHorney CA. The adherence estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin 2009;25:215-38. DOI 10.1185/03007990802619425